1.
1
Yu MC
, Yuan JM
.
Epidemiology of nasopharyngeal carcinoma
.
Semin Cancer Biol
. 2002;12:421–429
.
CrossRef
2.
2
Hsu MM
, Tu SM
.
Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy
.
Cancer
. 1983;52:362–368
.
3.
3
Chan AT
, Teo PM
, Huang DP
.
Pathogenesis and treatment of nasopharyngeal carcinoma
.
Semin Oncol
. 2004;31:794–801
.
Abstract | Full Text |
Full-Text PDF (301 KB)
|
CrossRef
4.
4
Chang JT
, Ko JY
, Hong RL
.
Recent advances in the treatment of nasopharyngeal carcinoma
.
J Formos Med Assoc
. 2004;103:496–510
.
MEDLINE
5.
5
Teo PM
, Chan AT
.
Treatment strategy and clinical experience
.
Semin Cancer Biol
. 2002;12:497–504
.
CrossRef
6.
6
Hong RL
, Ting LL
, Ko JY
, et al.
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
.
J Clin Oncol
. 2001;19:4305–4313
.
7.
7
Ng SH
, Joseph CT
, Chan SC
, et al.
Clinical usefulness of F18-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence
.
J Nucl Med
. 2004;45:1669–1676
.
MEDLINE
8.
8
Yen RF
, Hung RL
, Pan MH
, et al.
18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recur-rent nasopharyngeal carcinomas and comparison with magnetic resonance imaging
.
Cancer
. 2003;98:283–287
.
9.
9
Tsai MH
, Shiau YC
, Kao CH
, Shen YY
, Lin CC
, Lee CC
.
Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy
.
J Cancer Res Clin Oncol
. 2002;128:279–282
.
MEDLINE |
CrossRef
10.
10
Kao CH
, Shiau YC
, Shen YY
, Yen RF
.
Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99 m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography. Comparison with 18-fluoro-2-deoxyglucose positron emission tomography
.
Cancer
. 2002;94:1981–1986
.
11.
11
Yen RF
, Hong RL
, Tzen KY
, Pan MH
, Chen TH
.
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma
.
J Nucl Med
. 2005;46:770–774
.
MEDLINE
12.
12
Liu SH
, Chang JT
, Ng SH
, Chan SC
, Yen TC
.
False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient
.
Br J Radiol
. 2004;77:257–260
.
MEDLINE |
CrossRef
13.
13
Ho CL
.
Clinical PET imaging: an Asian perspective
.
Ann Acad Med Singapore
. 2004;33:155–165
.
MEDLINE
14.
14
Lee AW
, Sze WM
, Au JS
, et al.
Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience
.
Int J Radiat Oncol Biol Phys
. 2005;61:1107–1116
.
Abstract | Full Text |
Full-Text PDF (156 KB)
|
CrossRef
15.
15
Ng SH
, Chang JT
, Ko SF
, Wan YL
, Tang LM
, Chen WC
.
MRI in recurrent nasopharyngeal carcinoma
.
Neuroradiology
. 1999;41:855–862
.
MEDLINE |
CrossRef
16.
16
Chong VF
, Fan YF
.
Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT
.
Radiology
. 1997;202:463–470
.
MEDLINE
17.
17
Ng SH
, Liu HM
, Ko SF
, Hao SP
, Chong VF
.
Posttreatment imaging of the nasopharynx
.
Eur J Radiol
. 2002;44:82–95
.
CrossRef
18.
18
Gong QY
, Zheng GL
, Zhu HY
.
MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis
.
Comput Med Imaging Graph
. 1991;15:423–429
.
MEDLINE |
CrossRef
19.
19
Hung GU
, Tsai SC
, Lin WY
.
Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma
.
Clin Nucl Med
. 2005;30:558–559
.
MEDLINE |
CrossRef
20.
20
Lee AW
, Law SC
, Ng SH
, et al.
Retrospective analysis of nasopharyngeal carcinoma treated during 1976—1985: late complications following megavoltage irradiation
.
Br J Radiol
. 1992;65:918–928
.
MEDLINE |
CrossRef
21.
21
Lin YS
, Jen YM
, Lin JC
.
Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma
.
Cancer
. 2002;95:404–409
.
22.
22
Li JC
, Mayr NA
, Yuh WT
, Wang JZ
, Jiang GL
.
Cranial nerve involvement in nasopharyngeal carcinoma: response to radiotherapy and its clinical impact
.
Ann Otol Rhinol Laryngol
. 2006;115:340–345
.
MEDLINE
23.
23
Chang JT
, Lin CY
, Chen TM
, et al.
Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy
.
Int J Radiat Oncol Biol Phys
. 2005;63:1354–1360
.
Abstract | Full Text |
Full-Text PDF (168 KB)
|
CrossRef
24.
24
Yen RF
, Yen MF
, Hong RL
, Tzen KY
, Chien CR
, Chen TH
.
The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma
.
Acad Radiol
. 2009;16:54–60
.
Abstract | Full Text |
Full-Text PDF (859 KB)
|
CrossRef
25.
25
Comoretto M
, Balestreri L
, Borsatti E
, Cimitan M
, Franchin G
, Lise M
.
Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT
.
Radiology
. 2008;249:203–211
.
CrossRef
26.
26
Chan SC
, Ng SH
, Chang JT
, et al.
Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging
.
Eur J Nucl Med Mol Imaging
. 2006;33:1032–1040
.
MEDLINE